Jaguar's requesting advice from EMA on EU approval pathway for general diarrhea of FDA conditionally approved Canalevia® ...

Canalevia ®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from the FDA SAN FRANCISCO, CA / ACCESSWIRE / May 11, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" ...

Detailed price information for Jaguar Health Inc (JAGX-Q) from The Globe and Mail including charting and trades.

Conference attendees are invited to visit Jaguar Animal Health's exhibit booth to take part in a Take C.H.A.R.G.E. Spin the Wheel promotion for a chance to win an original painting made with the latex ...

SAN FRANCISCO, CA / ACCESSWIRE / March 30, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") under its Jaguar Animal Health tradename for the veterinary market, today announced that ...

Jaguar Animal Health, Inc. is an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value ...

Shares of Jaguar Animal Health, Inc. (JAGX) have been struggling lately and have lost 11.7% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which ...